Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
Tesla Is An AI Company That The Market Won’t Reward For Now
April 24, 2024
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
ESPR Stock News and Mentions of Esperion Therapeutics, Inc. Stocktwits
Updated: April 28, 2024 (09:14)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Esperion Therapeutics Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Esperion Therapeutics, Inc. (ESPR).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Esperion Therapeutics stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Esperion Therapeutics, Inc. (ESPR)
April 25, 2024 (12:50) / "Zacks Commentary" (by Zacks Equity Research)
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
In Article Trend: Bullish
April 12, 2024 (12:04) / "Benzinga" (by Avi Kapoor)
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Nurix Therapeutics ( NASDAQ:NRIX ) , Applied Digital ( NASDAQ:APLD )
U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday. Shares of Applied Digital Corporation APLD fell sharply in today's pre-market trading after the company reported worse-than-expected third-quarter financial results.
In Article Trend: Neutral
April 8, 2024 (12:49) / "Benzinga" (by Akanksha Bakshi)
Bitcoin, Ethereum, And Dogecoin Surge As Bitcoin Halving Approaches; Trump Vs. Biden: A Surprising Shift Sees One Candidate Increasingly Favored by Young Voters - Top Headlines Today While US Slept
Dormant Bitcoin Whale Springs Back To Life With $74M Binance Deposit Bitcoin ETFs, Halving To Power Crypto Market Past $5 Trillion Mark, Predicts Ripple CEO Crypto Analyst Says 'Crowd Sentiment' On This Ethereum-Killer Is Such That 'Being Contrarian Now Might Just Pay Off'
In Article Trend: Neutral
April 8, 2024 (10:05) / "Business Insider" (by Avi Kapoor)
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%. Here Are 20 Stocks Moving Premarket - Markets Insider ...
In Article Trend: Neutral
April 8, 2024 (09:15) / "Benzinga" (by Avi Kapoor)
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs ( NASDAQ:AEHL ) , Allarity Therapeutics ( NASDAQ:ALLR )
Shares of Esperion Therapeutics, Inc. ESPR shares rose sharply during today's pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations. Esperion Therapeutics shares climbed 7.1% to $3.47 pre-market trading.
In Article Trend: Neutral
April 7, 2024 (18:45) / "GlobeNewswire" (by Esperion Therapeutics)
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® ( bempedoic acid ) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
- Patients With Obesity Who Took NEXLETOL Were 23% Less Likely to Experience a Major Adverse Cardiovascular Event ( MACE-4 ) Compared to Placebo ...
In Article Trend: Neutral
April 3, 2024 (14:31) / "Benzinga" (by Avi Kapoor)
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday - Signet Jewelers ( NYSE:SIG ) , Dave & Buster's Enter ( NASDAQ:PLAY )
U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday. Shares of Signet Jewelers Limited SIG rose sharply during Wednesday's session after the company raised its FY25 guidance.
In Article Trend: Bullish
March 28, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)
Why Is Esperion Therapeutics ( ESPR ) Up 2% Since Last Earnings Report?
Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 27, 2024 (12:00) / "Benzinga" (by Globe Newswire)
One Biosciences Welcomes Dr. Scott Braunstein and Dr. Vincent Miller to its Board of Directors
PARIS, March 27, 2024 ( GLOBE NEWSWIRE ) -- One Biosciences, a Home Biosciences biotech company, leveraging the power of single-cell analysis and A.I. to identify a new generation of precision medicine targets and develop new treatments, today announced the appointments of Dr. Scott Braunstein, ...
In Article Trend: Neutral
March 25, 2024 (13:24) / "Benzinga" (by Vandana Singh)
Why Is Esperion Therapeutics Stock Trading Higher On Monday? - Esperion Therapeutics ( NASDAQ:ESPR )
Friday, the FDA approved broad new label expansions for Esperion Therapeutics Inc's ESPR NEXLETOL ( bempedoic acid ) Tablets and NEXLIZET ( bempedoic acid and ezetimibe ) Tablets based on CLEAR Outcomes data that include indications for cardiovascular risk reduction and expanded LDL-C lowering ...
In Article Trend: Neutral
March 25, 2024 (12:51) / "Benzinga" (by Akanksha Bakshi)
Bitcoin, Ethereum, Dogecoin Gain Momentum As Fresh Trading Week Starts: Analyst Says Altcoin Market 'Bottoming Out,' Eyes $70K For BTC This Wee; Boeing Labor Union Pushes For Board Voice: Report - Top Headlines Today While US Was Sleeping
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session Investor Sentiment Falls, But Dow Records Strongest Week Since December Will Trump Pull The Bankruptcy Trigger Before NY Civil Fraud Case Deadline? DOJ Veteran Expects A 'Deus Ex Machina' From Third ...
In Article Trend: Somewhat-Bullish
March 25, 2024 (12:03) / "Benzinga" (by Avi Kapoor)
Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket - Salarius Pharmaceuticals ( NASDAQ:SLRX )
Shares of Salarius Pharmaceuticals, Inc. SLRX rose sharply in today's pre-market trading following fourth-quarter results. Salarius Pharmaceuticals posted a net loss of $0.9 million, or 22 cents per share for the fourth quarter, narrower than the year-ago loss of $6.4 million, or $2.83 per share, ...
In Article Trend: Neutral
March 25, 2024 (09:34) / "Benzinga" (by Avi Kapoor)
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session - Esperion Therapeutics ( NASDAQ:ESPR ) , Masimo ( NASDAQ:MASI )
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. ESPR rose sharply in today's pre-market trading. The U.S.
In Article Trend: Bullish
March 22, 2024 (19:10) / "Benzinga" (by Globe Newswire)
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use - Esperion Therapeutics ( NASDAQ:ESPR )
- New Labels Expand Treatable Population to ~70 Million Patients in U.S. - - First LDL-C Lowering Non-Statin Indicated for Primary Prevention Patients - - Approvals Based on Positive CLEAR Outcomes Data and Reflect a Highly Differentiated Product Profile - - Positive CHMP Opinion Received.
In Article Trend: Neutral
March 22, 2024 (19:10) / "GlobeNewswire" (by Esperion Therapeutics)
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
- New Labels Expand Treatable Population to ~70 Million Patients in ...
In Article Trend: Neutral
March 22, 2024 (15:04) / "GlobeNewswire" (by Esperion Therapeutics)
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
- Positive CHMP Opinions Are Based On The Analyses Of The Phase 3 Of The CLEAR ( Cholesterol Lowering via Bempedoic Acid, an ATP Citrate Lyase ( ACL ) -Inhibiting Regimen ) Outcomes ...
In Article Trend: Neutral
March 1, 2024 (14:45) / "Zacks Commentary" (by Zacks Equity Research)
Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics are part of the Zacks Industry Outlook article.
In Article Trend: Somewhat-Bullish
February 29, 2024 (13:53) / "Zacks Commentary" (by Kinjel Shah)
5 Small Drug Stocks to Buy From a Rebounding Industry
Innovation is expected to continue to drive growth of the Medical-Drugs industry. UTHR, ESPR, HRTX, LYRA and ALDX may prove to be good additions to one's portfolio.
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website